2021
COVID‐19 vaccines are effective in people with obesity: A position statement from The Obesity Society
Butsch WS, Hajduk A, Cardel MI, Donahoo WT, Kyle TK, Stanford FC, Zeltser LM, Kotz CM, Jastreboff AM. COVID‐19 vaccines are effective in people with obesity: A position statement from The Obesity Society. Obesity 2021, 29: 1575-1579. PMID: 34212511, PMCID: PMC8441899, DOI: 10.1002/oby.23251.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedClinical Trials as TopicCOVID-19COVID-19 VaccinesHumansMiddle AgedObesitySARS-CoV-2Societies, MedicalYoung AdultConceptsCOVID-19 vaccineObesity SocietyCOVID-19-associated hospitalizationPosition statementEfficacy of vaccinesSARS-CoV-2Pfizer-BioNTechAvailable vaccinesUS FoodDrug AdministrationObesityVaccineEmergency useHigh efficacyPeer-reviewed literatureScientific evidenceCOVID-19EfficacyTime of publicationBriefing documentsDefinitive wayHospitalizationPatientsVaccinationAdministration
2012
Year in Diabetes 2012: The Diabetes Tsunami
Sherwin R, Jastreboff AM. Year in Diabetes 2012: The Diabetes Tsunami. The Journal Of Clinical Endocrinology & Metabolism 2012, 97: 4293-4301. PMID: 23185035, PMCID: PMC3513534, DOI: 10.1210/jc.2012-3487.BooksConceptsClinical trialsAmerican Diabetes Association/European AssociationNew-onset type 1 diabetesPrevalence of diabetesCurrent treatment optionsLarge clinical trialsRecent clinical trialsBenefits of exerciseDevelopment of obesityNormal glucose metabolismType 1 diabetesStudy of DiabetesΒ-cell functionNovel therapeutic targetCentral nervous systemObese childrenSignificant morbidityTreatment optionsEndocrine SocietyInpatient settingTreatment strategiesIndividualized careOptimal preventionGlucose metabolismOptimization of interventions